Some scientists surprised Oval Office used to release preliminary antiviral drug details
Thursday, April 30, 2020 - 10:00
in Health & Medicine
The top U.S. infectious disease official says concerns over leaks compelled him to reveal data on Gilead Sciences Inc.'s experimental drug remdesivir, the first in a scientifically rigorous clinical trial to show benefit in treating COVID-19.